These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28839954)

  • 1. The large tumor suppressor family: friend or foe?
    Kang W; Zhou Y; To KF
    J Thorac Dis; 2017 Jul; 9(7):1748-1751. PubMed ID: 28839954
    [No Abstract]   [Full Text] [Related]  

  • 2. STAT1 in cancer: friend or foe?
    Zhang Y; Liu Z
    Discov Med; 2017 Aug; 24(130):19-29. PubMed ID: 28950072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbial "friend-foe" identification in human intestine microsymbiocenosis].
    Bukharin OV; Petrunova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):46-51. PubMed ID: 22308727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer.
    Chen S; Zhang D
    FEBS Open Bio; 2015; 5():91-8. PubMed ID: 25709888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.
    Michetti CP; Griffen MM; Teicher EJ; Rodriguez JL; Seoudi H; Liu C; Lita E; Newcomb A
    Am J Surg; 2018 Dec; 216(6):1056-1062. PubMed ID: 30017306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vav1: Friend and Foe of Cancer.
    Guo F; Zheng Y
    Trends Cell Biol; 2017 Dec; 27(12):879-880. PubMed ID: 29097023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP10: friend and foe.
    Jochemsen AG; Shiloh Y
    Cell; 2010 Feb; 140(3):308-10. PubMed ID: 20144755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor ETS1 in lymphomas: friend or foe?
    Testoni M; Chung EY; Priebe V; Bertoni F
    Leuk Lymphoma; 2015 Jul; 56(7):1975-80. PubMed ID: 25363344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?
    Wen L; Gong P; Liang C; Shou D; Liu B; Chen Y; Bao C; Chen L; Liu X; Liang T; Gong W
    Oncotarget; 2016 Jun; 7(23):35490-6. PubMed ID: 27007054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy: is it cancer's friend or foe?
    Marx J
    Science; 2006 May; 312(5777):1160-1. PubMed ID: 16728626
    [No Abstract]   [Full Text] [Related]  

  • 11. Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between "Foe" and "Friend" During Tumor Malignant Transformation.
    Tian H; Zhang B; Li L; Wang G; Li H; Zheng J
    Front Oncol; 2020; 10():1692. PubMed ID: 32974209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGC1α: Friend or Foe in Cancer?
    Mastropasqua F; Girolimetti G; Shoshan M
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29361779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 Missense Mutations in Cancer: Friend or Foe?
    Okonska A; Felley-Bosco E
    Trends Cancer; 2019 Nov; 5(11):659-662. PubMed ID: 31735283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages in solid tumor: friend or foe.
    Pandey G
    Ann Transl Med; 2020 Aug; 8(16):1027. PubMed ID: 32953827
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular senescence in cancer treatment: friend or foe?
    Kahlem P; Dörken B; Schmitt CA
    J Clin Invest; 2004 Jan; 113(2):169-74. PubMed ID: 14722606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in endometriosis: Friend or foe?
    Zhan L; Li J; Wei B
    Biochem Biophys Res Commun; 2018 Jan; 495(1):60-63. PubMed ID: 29107692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
    Kim H
    Ann Coloproctol; 2015 Aug; 31(4):121-2. PubMed ID: 26361612
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirtuin 1 in malignant transformation: friend or foe?
    Fang Y; Nicholl MB
    Cancer Lett; 2011 Jul; 306(1):10-4. PubMed ID: 21414717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells in ovarian cancer: friend or foe?
    Walankiewicz M; Grywalska E; Polak G; Kotarski J; Siwicka-Gieroba DJ; Roliński J
    Cent Eur J Immunol; 2017; 42(4):383-389. PubMed ID: 29472817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 in rheumatoid arthritis: friend or foe?
    Müller-Ladner U; Nishioka K
    Arthritis Res; 2000; 2(3):175-8. PubMed ID: 11094424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.